The effects of treatment can vary depending on the person's age, gender, health status, and glutathione levels
(RMD), the global leader in CPAP and sleep apnea therapy, reported fiscal Q3 2026 results on April 30 with revenue of $1.43 billion up 11% year-over-year and ahead of the $1.42 billion street estimate
In people with type 2 diabetes, GLP-1 receptor agonists help in glucose control, weight loss, and cardiovascular benefits
Yes, medications can slow down the disease and also helps in the regrowth of new hairs, depending upon the grade of hair loss
Response by Patient Characteristics Subgroup analyses revealed important patterns about who responds best to treatment: By starting BMI: Patients with BMI 30-35 achieved 26.8% average weight loss, those with BMI 35-40 achieved 24.1%, and those with BMI over 40 achieved 21.3%
Johnson TE et al